Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1969 1
1973 1
1974 1
1977 1
1978 2
1980 3
1981 1
1983 7
1984 4
1985 1
1986 1
1987 6
1988 4
1989 1
1990 6
1991 2
1992 1
1993 6
1994 6
1995 6
1996 7
1997 9
1998 6
1999 14
2000 6
2001 10
2002 15
2003 12
2004 17
2005 16
2006 18
2007 16
2008 17
2009 19
2010 14
2011 17
2012 17
2013 25
2014 27
2015 37
2016 40
2017 41
2018 47
2019 45
2020 56
2021 71
2022 48
2023 57
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

710 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for george retinas
Search for George Retsinas instead (2 results)
VEGFR1 signaling in retinal angiogenesis and microinflammation.
Uemura A, Fruttiger M, D'Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. Uemura A, et al. Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25. Prog Retin Eye Res. 2021. PMID: 33640465 Free PMC article. Review.
Although much research has been conducted on VEGFR2 to elucidate its key role in retinal diseases, recent efforts have shown the importance and involvement of VEGFR1 and its family of ligands in angiogenesis, vascular permeability, and microinflammatory cascades within the ret …
Although much research has been conducted on VEGFR2 to elucidate its key role in retinal diseases, recent efforts have shown the importance …
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.
Lois N, Campbell C, Waugh N, Azuara-Blanco A, Maredza M, Mistry H, McAuley D, Acharya N, Aslam TM, Bailey C, Chong V, Downey L, Eleftheriadis H, Fatum S, George S, Ghanchi F, Groppe M, Hamilton R, Menon G, Saad A, Sivaprasad S, Shiew M, Steel DH, Talks JS, Doherty P, McDowell C, Clarke M; DIAMONDS Study Group. Lois N, et al. Ophthalmology. 2023 Jan;130(1):14-27. doi: 10.1016/j.ophtha.2022.08.012. Epub 2022 Aug 13. Ophthalmology. 2023. PMID: 35973593 Free article. Clinical Trial.
A Life in Vision.
Dowling JE. Dowling JE. Annu Rev Vis Sci. 2018 Sep 15;4:1-23. doi: 10.1146/annurev-vision-091517-034222. Annu Rev Vis Sci. 2018. PMID: 30222531
I was drawn into research in George Wald's laboratory at Harvard, where as an undergraduate and graduate student, I studied vitamin A deficiency and dark adaptation. A chance observation while an assistant professor at Harvard led to the major research of my career-to unde …
I was drawn into research in George Wald's laboratory at Harvard, where as an undergraduate and graduate student, I studied vitamin A …
GWAS on retinal vasculometry phenotypes.
Jiang X, Hysi PG, Khawaja AP, Mahroo OA, Xu Z, Hammond CJ, Foster PJ, Welikala RA, Barman SA, Whincup PH, Rudnicka AR, Owen CG, Strachan DP; UK Biobank Eye and Vision Consortium. Jiang X, et al. PLoS Genet. 2023 Feb 9;19(2):e1010583. doi: 10.1371/journal.pgen.1010583. eCollection 2023 Feb. PLoS Genet. 2023. PMID: 36757925 Free PMC article.
The clinical relevance of visualising the peripheral retina.
Quinn N, Csincsik L, Flynn E, Curcio CA, Kiss S, Sadda SR, Hogg R, Peto T, Lengyel I. Quinn N, et al. Prog Retin Eye Res. 2019 Jan;68:83-109. doi: 10.1016/j.preteyeres.2018.10.001. Epub 2018 Oct 10. Prog Retin Eye Res. 2019. PMID: 30316018 Free article. Review.
As wide field retinal imaging, capturing both the central and peripheral retina up to 200 eccentricity, is becoming readily available the question is: what is it that we gain by imaging the periphery? ...In this review, we explore the anatomy and physiology of the peripher …
As wide field retinal imaging, capturing both the central and peripheral retina up to 200 eccentricity, is becoming readily available …
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model.
Sharma R, George A, Nimmagadda M, Ortolan D, Karla BS, Qureshy Z, Bose D, Dejene R, Liang G, Wan Q, Chang J, Jha BS, Memon O, Miyagishima KJ, Rising A, Lal M, Hanson E, King R, Campos MM, Ferrer M, Amaral J, McGaughey D, Bharti K. Sharma R, et al. Nat Commun. 2021 Dec 15;12(1):7293. doi: 10.1038/s41467-021-27488-x. Nat Commun. 2021. PMID: 34911940 Free PMC article.
Measuring and using light in the melanopsin age.
Lucas RJ, Peirson SN, Berson DM, Brown TM, Cooper HM, Czeisler CA, Figueiro MG, Gamlin PD, Lockley SW, O'Hagan JB, Price LL, Provencio I, Skene DJ, Brainard GC. Lucas RJ, et al. Trends Neurosci. 2014 Jan;37(1):1-9. doi: 10.1016/j.tins.2013.10.004. Epub 2013 Nov 25. Trends Neurosci. 2014. PMID: 24287308 Free PMC article. Review.
Anti-VEGF Therapy and the Retina: An Update.
Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, Ramskold L, Pasu S. Tah V, et al. J Ophthalmol. 2015;2015:627674. doi: 10.1155/2015/627674. Epub 2015 Aug 31. J Ophthalmol. 2015. PMID: 26417453 Free PMC article. Review.
710 results